Pasithea Therapeutics Corp

Penny Stocks Biotech Stocks Healthcare Stocks

$0.74

-0.04 (-4.88%)

Analyst Consensus

Strong Buy

Analysts

Moderate

Coverage

Buy 6 86%

Hold 1 14%

Sell 0 0%

Price Target

Analyst Price Target +3,537.8% upside

Low Target $19.73

Average Target $26.92

High Target $29.00

Current Price $0.74

Current
$0.74

Target
$26.92

$19.73 $26.92 avg $29.00

Scenario Analysis

Bear Case

$19.73

2,566.2%

Low target

Base Case

$26.92

+3,537.8%

Avg target

Bull Case

$29.00

+3,818.9%

High target

Risk/Reward

1.5x

Balanced

Price in Context

52-Week High

$3.79

-80.5% from high

52-Week Low

$0.28

+163.3% from low

Target vs 52W High

$26.92

+610.3% vs high

Peer Consensus — Biotechnology

Stock	Consensus	Analysts	Buy %	Target	Upside
ABBV Abbvie Inc	Buy	39	69%	$257.58	+19.9%
AMGN Amgen Inc	Hold	42	50%	$190.87	-46.1%
GILD Gilead Sciences Inc	Strong Buy	38	79%	$362.68	+157.7%
VRTX Vertex Pharmaceuticals Inc	Strong Buy	39	79%	$438.34	-2.5%
REGN Regeneron Pharmaceuticals	Strong Buy	36	75%	$76.80	-90.1%
ALNY Alnylam Pharmaceuticals Inc	Strong Buy	36	78%	$102.31	-69.0%
INSM Insmed Inc	Strong Buy	26	92%	$143.40	-12.3%
NTRA Natera Inc	Strong Buy	27	89%	$142.91	-29.5%